Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| METHODE ELECTRONICS INCMEI · Entity 1870 | Director · CEO and President | September 22, 2026 | September 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
METHODE ELECTRONICS INC
Report date September 22, 2026 · Filed September 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 150,000 |
Reported balance
After 2026-09-22 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-22 · Grant · Acquired 15,000 · Balance 150,000 F1: Each restricted stock unit represents a contingent right to receive one share of Methode common stock upon vesting, granted under the Company's 2026 Omnibus Incentive Plan. F2: The restricted stock units vest in full on the fifth anniversary of the grant date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 170,840 |
Reported balance
After 2026-09-22 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-22 · Grant · Acquired 155,840 · Balance 170,840 F3: The Restricted Stock Units will vest 33% on 9/22/27; 33% on 9/22/28; and 34% on 9/22/29. |
| Common StockSEC Table I · non-derivative | Direct | 366,324 |
Reported balance
Holding disclosure · report date 2026-09-22 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 366,324 |
| Common StockSEC Table I · non-derivative | IndirectJoint account with spouse | 32,733 |
Reported balance
Holding disclosure · report date 2026-09-22 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 32,733 |
| Common StockSEC Table I · non-derivative | IndirectHeld in Methode 401(k) Plan | 1,987 |
Reported balance
Holding disclosure · report date 2026-09-22 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,987 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Methode common stock upon vesting, granted under the Company's 2026 Omnibus Incentive Plan.
F2: The restricted stock units vest in full on the fifth anniversary of the grant date.
F3: The Restricted Stock Units will vest 33% on 9/22/27; 33% on 9/22/28; and 34% on 9/22/29.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
STONERIDGE INC
Report date January 30, 2023 · Filed February 01, 2023
Section 16 reporting ended · disclosed 2023-02-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Share UnitsSEC Table II · derivative / convertible security | Direct | 187,425 |
Reported balance
After 2023-01-30 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-01-30 · Grant · Acquired 40,000 · Balance 187,425 F1: 40,000 share units were granted to the Reporting Person under the Company's Long-Term Incentive Plan pursuant to that certain Consulting Services Agreement, dated January 30, 2023, by and between the Reporting Person and the Company. Assuming the Reporting Person's compliance with the Consulting Services Agreement the 40,000 share units will vest and be paid on a one-for-one basis in Company common shares on the six month anniversary of the Consulting Services Agreement. F2: In connection with the Reporting Person's resignation of employment and the Consulting Services Agreement, subject to the Reporting Person's compliance with the Consulting Services Agreement, the Reporting Person's March 9, 2020 time-based 65,124 share unit grant will vest on March 9, 2023 and be paid on a one-for-one basis in Company common shares. The remaining amounts (other than the 40,000 share unit grant described in footnote no. 1) were forfeited upon the Reporting Person's resignation. |
| Common Shares, without par valueSEC Table I · non-derivative | Direct | 215,426 |
Reported balance
Holding disclosure · report date 2023-01-30 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 215,426 |
Filing footnotes · ownership attribution and instrument terms
F1: 40,000 share units were granted to the Reporting Person under the Company's Long-Term Incentive Plan pursuant to that certain Consulting Services Agreement, dated January 30, 2023, by and between the Reporting Person and the Company. Assuming the Reporting Person's compliance with the Consulting Services Agreement the 40,000 share units will vest and be paid on a one-for-one basis in Company common shares on the six month anniversary of the Consulting Services Agreement.
F2: In connection with the Reporting Person's resignation of employment and the Consulting Services Agreement, subject to the Reporting Person's compliance with the Consulting Services Agreement, the Reporting Person's March 9, 2020 time-based 65,124 share unit grant will vest on March 9, 2023 and be paid on a one-for-one basis in Company common shares. The remaining amounts (other than the 40,000 share unit grant described in footnote no. 1) were forfeited upon the Reporting Person's resignation.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 30, 2017 Filed Jan 4, 2018 20:26 UTC Amendment | STONERIDGE INC SRI · Entity 6313 | Tax withholdingCommon Shares, without par value | 9,129 | $18.40 | $167,973.60 |
DisclosureSEC source: 0001331471-18-000002 · primary_doc.xml · nonDerivative · entry 2 DeGaynor Jonathan B · CIK 0001637951 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,726 Read SEC document |
| March 30, 2017 Filed Jan 4, 2018 20:26 UTC Amendment | STONERIDGE INC SRI · Entity 6313 | Exercise / conversionCommon Shares, without par value | 21,885 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001331471-18-000002 · primary_doc.xml · nonDerivative · entry 1 DeGaynor Jonathan B · CIK 0001637951 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,855 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On March 30, 2015 the Reporting Person was granted Performance Shares. Those Performance Shares included 21,855 time-based Performance Shares that vested and were paid on a one-for-one basis in Common Shares on March 30, 2017. Read SEC document |
| March 06, 2017 Filed Mar 8, 2017 19:48 UTC | STONERIDGE INC SRI · Entity 6313 | GrantPerformance Shares · Derivative | 93,580 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001331471-17-000012 · primary_doc.xml · derivative · entry 1 DeGaynor Jonathan B · CIK 0001637951 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 392,765 Underlying: Common Shares, without par value · 93,580 shares Expires not disclosed F1 · derivative.exercise_price: Each Performance Share represents the contingent right to receive one Company Common Share. Provided that the Reporting Person remains employed on March 6, 2020 29,500 Common Shares shall be earned and depending on continued employment and Company performance 64,030 Common Shares may be earned. F1 · price: Each Performance Share represents the contingent right to receive one Company Common Share. Provided that the Reporting Person remains employed on March 6, 2020 29,500 Common Shares shall be earned and depending on continued employment and Company performance 64,030 Common Shares may be earned. F1 · derivative.exercise_date: Each Performance Share represents the contingent right to receive one Company Common Share. Provided that the Reporting Person remains employed on March 6, 2020 29,500 Common Shares shall be earned and depending on continued employment and Company performance 64,030 Common Shares may be earned. F1 · derivative.expiration_date: Each Performance Share represents the contingent right to receive one Company Common Share. Provided that the Reporting Person remains employed on March 6, 2020 29,500 Common Shares shall be earned and depending on continued employment and Company performance 64,030 Common Shares may be earned. F2 · balance_after: Total includes grants of Performance Shares made to the Reporting Person in 2015 and 2016. Read SEC document |
| March 06, 2017 Filed Jan 4, 2018 20:13 UTC Amendment | STONERIDGE INC SRI · Entity 6313 | GrantPerformance Shares · Derivative | 98,895 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001331471-18-000001 · primary_doc.xml · derivative · entry 1 DeGaynor Jonathan B · CIK 0001637951 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 398,080 Underlying: Common Shares, without par value · 98,895 shares Expires not disclosed F1 · derivative.exercise_price: Each Performance Share represents the contingent right to receive one Common Share. Provided that the Reporting Person remains employed on March 6, 2020 31,230 Common Shares shall be earned and depending on continued employment and Company performance 67,665 Common Shares may be earned. F1 · price: Each Performance Share represents the contingent right to receive one Common Share. Provided that the Reporting Person remains employed on March 6, 2020 31,230 Common Shares shall be earned and depending on continued employment and Company performance 67,665 Common Shares may be earned. F1 · derivative.exercise_date: Each Performance Share represents the contingent right to receive one Common Share. Provided that the Reporting Person remains employed on March 6, 2020 31,230 Common Shares shall be earned and depending on continued employment and Company performance 67,665 Common Shares may be earned. F1 · derivative.expiration_date: Each Performance Share represents the contingent right to receive one Common Share. Provided that the Reporting Person remains employed on March 6, 2020 31,230 Common Shares shall be earned and depending on continued employment and Company performance 67,665 Common Shares may be earned. F2 · balance_after: Total includes grants of Performance Shares made to the Reporting Person in 2015 and 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.